Scientific Library

tebu-bio signed recently a distribution agreement with HemaCare Corp. Built on a 36-year history in apheresis collection, HemaCare is a leader in cell and tissue collection and processing, providing high-quality

The transition from non-invasive phenotype to invasive phenotype of tumor cells marks the switch from a benign tumor to a more malignant form of cancer. Understanding the mechanisms underlying this hallmark

To overcome current cell model limitations, bit.bio have developed a new, innovative technology to reprogram human stem cells with precise control of transcription factor expression through iPSC engineering.

As detailed in a separate post, bit.bio have developed a novel cellular reprogramming technology, opti-ox™¹ (optimized inducible overexpression), that can generate functional cells with high consistency

Over the years, people have started to understand the need for science to get materials to learn and progress. Materials include not only medical tools, but also biological ones.

Many people still ignore